For example, melanoma patients receiving anti-PD-1 therapy exhibit elevated levels of specific microbial species, including Bifidobacterium longum, Collinsella aerofaciens, and Enterococcus faecium, highlighting the microbiome’s relevance in ICI response [463]. This evidence concerns the gene PDCD1 and melanoma.